Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Align Technology    ALGN

ALIGN TECHNOLOGY (ALGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies

Anaïs Lozach

Analyst
 
share with twitter share with LinkedIn share with facebook
share via e-mail

The technical configuration is positive

Strategy published on 12/06/2017 | 14:53
long trade
Live
Entry price : 227.89$ | Target : 267$ | Stop-loss : 207.5$ | Potential : 17.16%
Align Technology's shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Investors have an opportunity to buy the stock and target the $ 267.
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

Strengths
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Historically, the company has been releasing figures that are above expectations.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past twelve months, EPS forecast has been revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 153.5 USD

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 254.76.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 62.29 and 52 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Ratings chart
Subsector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalisation (M$)Investor Rating
ALIGN TECHNOLOGY151.10%18 892
MEDTRONIC PLC13.81%110 879
BAXTER INTERNATIONAL43.26%35 262
C R BARD INC48.14%24 200
ZIMMER BIOMET HOLDINGS INC9.86%22 985
HOYA CORPORATION13.11%19 055
TERUMO CORP21.16%17 661
SYSMEX CORP27.47%15 986
DENTSPLY SIRONA INC12.58%15 173
BIO-RAD LABORATORIES, INC.39.88%8 798
STERIS PLC31.68%7 494
Autres valeurs du secteur
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2017 1 448 M
EBIT 2017 343 M
Net income 2017 299 M
Finance 2017 545 M
Yield 2017 -
P/E ratio 2017 64,56
P/E ratio 2018 53,87
EV / Sales 2017 12,7x
EV / Sales 2018 10,2x
Capitalization 18 892 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing -
Middle Term Timing -
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ALIGN TECHNOLOGY
Duration : Period : Day
Align Technology Technical Analysis Chart | ALGN | US0162551016 | 4-Traders
Duration : Period : Week
Align Technology Technical Analysis Chart | ALGN | US0162551016 | 4-Traders